Oncternal Therapeutics Statistics
Total Valuation
ONCT has a market cap or net worth of $20.72 million. The enterprise value is -$6.03 million.
| Market Cap | 20.72M |
| Enterprise Value | -6.03M |
Important Dates
The next estimated earnings date is Thursday, August 8, 2024, after market close.
| Earnings Date | Aug 8, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
ONCT has 2.96 million shares outstanding. The number of shares has increased by 1.13% in one year.
| Shares Outstanding | 2.96M |
| Shares Change (YoY) | +1.13% |
| Shares Change (QoQ) | +0.33% |
| Owned by Insiders (%) | 9.23% |
| Owned by Institutions (%) | 16.03% |
| Float | 2.71M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 18.00 |
| Forward PS | 23.71 |
| PB Ratio | 0.90 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.66, with a Debt / Equity ratio of 0.01.
| Current Ratio | 4.66 |
| Quick Ratio | n/a |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -107.70% and return on invested capital (ROIC) is -165.27%.
| Return on Equity (ROE) | -107.70% |
| Return on Assets (ROA) | -91.00% |
| Return on Capital (ROIC) | -165.27% |
| Revenue Per Employee | $38,367 |
| Profits Per Employee | -$1.21M |
| Employee Count | 30 |
| Asset Turnover | 0.03 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -18.98% in the last 52 weeks. The beta is 1.36, so ONCT's price volatility has been higher than the market average.
| Beta (5Y) | 1.36 |
| 52-Week Price Change | -18.98% |
| 50-Day Moving Average | 8.17 |
| 200-Day Moving Average | 8.14 |
| Relative Strength Index (RSI) | 38.03 |
| Average Volume (20 Days) | 7,049 |
Short Selling Information
The latest short interest is 20,424, so 0.69% of the outstanding shares have been sold short.
| Short Interest | 20,424 |
| Short Previous Month | 20,152 |
| Short % of Shares Out | 0.69% |
| Short % of Float | 0.75% |
| Short Ratio (days to cover) | 3.47 |
Income Statement
In the last 12 months, ONCT had revenue of $1.15 million and -$36.38 million in losses. Loss per share was -$12.26.
| Revenue | 1.15M |
| Gross Profit | 1.15M |
| Operating Income | -38.35M |
| Pretax Income | -36.38M |
| Net Income | -36.38M |
| EBITDA | -36.21M |
| EBIT | -36.38M |
| Loss Per Share | -$12.26 |
Balance Sheet
The company has $27.03 million in cash and $278,000 in debt, giving a net cash position of $26.75 million or $9.04 per share.
| Cash & Cash Equivalents | 27.03M |
| Total Debt | 278,000 |
| Net Cash | 26.75M |
| Net Cash Per Share | $9.04 |
| Equity (Book Value) | 22.93M |
| Book Value Per Share | 7.75 |
| Working Capital | 22.39M |
Cash Flow
| Operating Cash Flow | -28.63M |
| Capital Expenditures | n/a |
| Free Cash Flow | -28.63M |
| FCF Per Share | -$9.68 |
Margins
Gross margin is 100.00%, with operating and profit margins of -3,331.89% and -3,160.73%.
| Gross Margin | 100.00% |
| Operating Margin | -3,331.89% |
| Pretax Margin | -3,160.73% |
| Profit Margin | -3,160.73% |
| EBITDA Margin | -3,145.96% |
| EBIT Margin | -3,160.73% |
| FCF Margin | -2,487.66% |
Dividends & Yields
ONCT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.13% |
| Shareholder Yield | -1.13% |
| Earnings Yield | -175.60% |
| FCF Yield | -138.21% |
Analyst Forecast
The average price target for ONCT is $28.33, which is 304.71% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $28.33 |
| Price Target Difference | 304.71% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on January 8, 2024. It was a reverse split with a ratio of 1:20.
| Last Split Date | Jan 8, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:20 |
Scores
ONCT has an Altman Z-Score of -11.06 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -11.06 |
| Piotroski F-Score | 2 |